NYSE:TFXMedical Equipment
How Teleflex’s (TFX) BIOTRONIK Acquisition and Raised Guidance May Shape Its 2025 Growth Path
Earlier this month, Teleflex Incorporated’s Board of Directors declared a quarterly dividend of US$0.34 per share, and the company reported second quarter sales of US$780.89 million with net income of US$122.58 million, alongside raised full-year guidance following the acquisition of BIOTRONIK’s Vascular Intervention business.
Teleflex’s updated outlook now reflects expected higher 2025 revenues and earnings, citing acquisition-related expansion and a positive impact from recent foreign...